All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
HONG KONG – A collaborative team from Hong Kong and mainland China has discovered an antiviral peptide that is a promising candidate for treating patients infected with the emergent Middle East respiratory syndrome (MERS) coronavirus, for which there are currently no effective treatments.